By transgenic expression of ovalbumin (OVA) as a model self antigen in the β cells of the pancreas, we have shown that self tolerance can be maintained by the cross-presentation of this antigen on dendritic cells in the draining lymph nodes. Such cross-presentation causes initial activation of OVA-specific CD8 T cells, which proliferate but are ultimately deleted; a process referred to as cross-tolerance. Here, we investigated the molecular basis of cross-tolerance. Deletion of CD8 T cells was prevented by overexpression of Bcl-2, indicating that cross-tolerance was mediated by a Bcl-2 inhibitable pathway. Recently, Bim, a pro-apoptotic Bcl-2 family member whose function can be inhibited by Bcl-2, was found to play a critical role in the deletion of autoreactive thymocytes, leading us to examine its role in cross-tolerance. Bim-deficient T cells were not deleted in response to cross-presented self-antigen, strongly implicating Bim as the pro-apoptotic mediator of cross-tolerance.
Skip Nav Destination
Article navigation
7 October 2002
Article|
September 30 2002
Peripheral Deletion of Autoreactive CD8 T Cells by Cross Presentation of Self-Antigen Occurs by a Bcl-2–inhibitable Pathway Mediated by Bim
Gayle M. Davey,
Gayle M. Davey
1The Walter and Eliza Hall Institute of Medical Research, P.O. Royal Melbourne Hospital, Parkville 3050, Victoria, Australia
Search for other works by this author on:
Christian Kurts,
Christian Kurts
2Department of Nephrology and Immunology, University of Aachen, 52074 Aachen, Germany
Search for other works by this author on:
Jacques F.A.P. Miller,
Jacques F.A.P. Miller
1The Walter and Eliza Hall Institute of Medical Research, P.O. Royal Melbourne Hospital, Parkville 3050, Victoria, Australia
Search for other works by this author on:
Philippe Bouillet,
Philippe Bouillet
1The Walter and Eliza Hall Institute of Medical Research, P.O. Royal Melbourne Hospital, Parkville 3050, Victoria, Australia
Search for other works by this author on:
Andreas Strasser,
Andreas Strasser
1The Walter and Eliza Hall Institute of Medical Research, P.O. Royal Melbourne Hospital, Parkville 3050, Victoria, Australia
Search for other works by this author on:
Andrew G. Brooks,
Andrew G. Brooks
3The Department of Microbiology and Immunology, University of Melbourne, Parkville 3052, Victoria, Australia
Search for other works by this author on:
Francis R. Carbone,
Francis R. Carbone
3The Department of Microbiology and Immunology, University of Melbourne, Parkville 3052, Victoria, Australia
Search for other works by this author on:
William R. Heath
William R. Heath
1The Walter and Eliza Hall Institute of Medical Research, P.O. Royal Melbourne Hospital, Parkville 3050, Victoria, Australia
Search for other works by this author on:
Gayle M. Davey
1The Walter and Eliza Hall Institute of Medical Research, P.O. Royal Melbourne Hospital, Parkville 3050, Victoria, Australia
Christian Kurts
2Department of Nephrology and Immunology, University of Aachen, 52074 Aachen, Germany
Jacques F.A.P. Miller
1The Walter and Eliza Hall Institute of Medical Research, P.O. Royal Melbourne Hospital, Parkville 3050, Victoria, Australia
Philippe Bouillet
1The Walter and Eliza Hall Institute of Medical Research, P.O. Royal Melbourne Hospital, Parkville 3050, Victoria, Australia
Andreas Strasser
1The Walter and Eliza Hall Institute of Medical Research, P.O. Royal Melbourne Hospital, Parkville 3050, Victoria, Australia
Andrew G. Brooks
3The Department of Microbiology and Immunology, University of Melbourne, Parkville 3052, Victoria, Australia
Francis R. Carbone
3The Department of Microbiology and Immunology, University of Melbourne, Parkville 3052, Victoria, Australia
William R. Heath
1The Walter and Eliza Hall Institute of Medical Research, P.O. Royal Melbourne Hospital, Parkville 3050, Victoria, Australia
Address correspondence to William R. Heath, Immunology Division, The Walter and Eliza Hall Institute, P.O. Royal Melbourne Hospital, Parkville 3050, Victoria, Australia. Phone: 61-3-9345-2482; Fax: 61-3-9347-0852; E-mail: [email protected]; or Francis R. Carbone, Department of Microbiology and Immunology, University of Melbourne, Parkville 3052, Victoria, Australia; Phone: 61-3-8344-9723; Fax: 61-3-9347-1540; E-mail: [email protected]
*
Abbreviations used in this paper: AICD, activation-induced cell death; CFSE, carboxy fluorescein diacetate succinimidyl ester; DC, dendritic cell; γc, common γ chain cytokine receptor; mOVA, membrane-bound ovalbumin; RIP, rat insulin promoter; SEB, staphylococcus enterotoxin B.
Received:
May 05 2002
Revision Received:
July 26 2002
Accepted:
August 14 2002
Online ISSN: 1540-9538
Print ISSN: 0022-1007
The Rockefeller University Press
2002
J Exp Med (2002) 196 (7): 947–955.
Article history
Received:
May 05 2002
Revision Received:
July 26 2002
Accepted:
August 14 2002
Citation
Gayle M. Davey, Christian Kurts, Jacques F.A.P. Miller, Philippe Bouillet, Andreas Strasser, Andrew G. Brooks, Francis R. Carbone, William R. Heath; Peripheral Deletion of Autoreactive CD8 T Cells by Cross Presentation of Self-Antigen Occurs by a Bcl-2–inhibitable Pathway Mediated by Bim . J Exp Med 7 October 2002; 196 (7): 947–955. doi: https://doi.org/10.1084/jem.20020827
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionSuggested Content
Email alerts
Advertisement